The Manufacturers Life Insurance Company Purchases New Position in Chemed Corporation $CHE

Key Points

• The Manufacturers Life Insurance Company bought 9,475 shares of Chemed, worth approximately $4.4 million, while institutional investors collectively own 95.85% of the company.
• Chemed beat quarterly expectations with $6.06 in EPS and $673.25 million in revenue, up 8.8% year over year. Analysts maintain a consensus “Hold” rating with an average price target of $530.75.
• The company raised its quarterly dividend from $0.60 to $0.70 per share, implying an annualized dividend of $2.80 and a 0.5% yield; insiders have sold 6,537 shares worth about $3.4 million over the past 90 days.

The Manufacturers Life Insurance Company purchased a new position in Chemed Corporation (NYSE:CHE - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 9,475 shares of the company's stock, valued at approximately $4,413,000. The Manufacturers Life Insurance Company owned approximately 0.07% of Chemed at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of CHE. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Chemed by 2,444,879.3% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company's stock worth $2,374,667,000 after acquiring an additional 5,549,876 shares during the period. BlackRock Inc. purchased a new position in shares of Chemed in the 2nd quarter valued at approximately $691,290,000. JPMorgan Chase & Co. boosted its position in shares of Chemed by 4.4% during the fourth quarter. JPMorgan Chase & Co. now owns 521,900 shares of the company's stock valued at $223,301,000 after purchasing an additional 21,932 shares in the last quarter. AQR Capital Management LLC boosted its position in shares of Chemed by 89.2% during the fourth quarter. AQR Capital Management LLC now owns 325,579 shares of the company's stock valued at $139,302,000 after purchasing an additional 153,469 shares in the last quarter. Finally, TD Asset Management Inc grew its stake in Chemed by 7.5% in the fourth quarter. TD Asset Management Inc now owns 324,546 shares of the company's stock worth $138,860,000 after purchasing an additional 22,715 shares during the period. 95.85% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on CHE. Bank of America reiterated a "neutral" rating on shares of Chemed in a report on Wednesday, July 29th. Oppenheimer upped their target price on shares of Chemed from $500.00 to $590.00 and gave the stock an "outperform" rating in a research report on Friday, July 31st. Weiss Ratings upgraded shares of Chemed from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday, July 17th. Royal Bank Of Canada lifted their price target on shares of Chemed from $436.00 to $548.00 and gave the company a "sector perform" rating in a research report on Thursday, July 30th. Finally, Wall Street Zen raised shares of Chemed from a "hold" rating to a "strong-buy" rating in a research note on Saturday, August 1st. One equities research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $530.75.

Chemed Stock Down 1.0%

CHE stock opened at $518.26 on Tuesday. Chemed Corporation has a 1-year low of $365.20 and a 1-year high of $557.00. The business has a fifty day moving average price of $511.08 and a 200-day moving average price of $450.15. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89. The stock has a market capitalization of $6.77 billion, a P/E ratio of 26.03, a P/E/G ratio of 1.98 and a beta of 0.51.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, beating the consensus estimate of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The company had revenue of $673.25 million for the quarter, compared to analysts' expectations of $665.04 million. During the same period last year, the firm posted $4.27 earnings per share. Chemed's revenue was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Equities analysts forecast that Chemed Corporation will post 23.18 earnings per share for the current fiscal year.

Chemed Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th will be issued a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Monday, August 17th. This is a boost from Chemed's previous quarterly dividend of $0.60. Chemed's payout ratio is 14.06%.

Insider Activity at Chemed

In other news, Director Andrea R. Lindell sold 1,347 shares of Chemed stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the sale, the director directly owned 4,578 shares in the company, valued at $2,047,876.74. The trade was a 22.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Patrick P. Grace sold 190 shares of the business's stock in a transaction that occurred on Friday, July 31st. The shares were sold at an average price of $532.00, for a total transaction of $101,080.00. Following the transaction, the director directly owned 3,533 shares of the company's stock, valued at $1,879,556. The trade was a 5.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 6,537 shares of company stock worth $3,406,014. 3.33% of the stock is owned by insiders.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source